NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

慢性特發性便秘治療市場:全球產業分析·市場規模·佔有率·成長·趨勢·預測 (2020∼2030年)

Chronic Idiopathic Constipation Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

出版商 Transparency Market Research 商品編碼 987689
出版日期 內容資訊 英文 295 Pages
商品交期: 最快1-2個工作天內
價格
慢性特發性便秘治療市場:全球產業分析·市場規模·佔有率·成長·趨勢·預測 (2020∼2030年) Chronic Idiopathic Constipation Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
出版日期: 2020年12月15日內容資訊: 英文 295 Pages
簡介

本報告提供全球慢性特發性便秘治療市場相關調查,提供全球市場概要,成長要素,市場趨勢,所說的課題的市場動態相關資訊,加上各市場區隔·各區各國的市場分析,並提供主要企業簡介等資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理:全球慢性特發性便秘治療市場

第4章 市場概要

  • 簡介
    • 醫藥品分類定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球慢性特發性便秘治療市場分析與預測

第5章 重要考察

  • 開發平台分析
  • COVID-19疫情對產業的影響(價值鏈及短期/中期/長期的影響)
  • 各疾病盛行率:全球/各地區
  • 主要的發展

第6章 全球慢性特發性便秘治療市場分析與預測:各醫藥品分類

  • 簡介&定義
  • 主要調查結果/發展
  • 全球市場規模預測 (以金額為準):各醫藥品分類
    • 血清素-4(5-Ht4)受體受體激動劑
    • 鳥苷酸環化酶C激動劑
    • 瀉藥
    • 刺激劑
    • 其他
  • 市場魅力分析:各醫藥品分類

第7章 全球慢性特發性便秘治療市場分析與預測:各給藥途徑

  • 簡介&定義
  • 主要調查結果/發展
  • 全球市場規模預測 (以金額為準):各給藥途徑
    • 口服
    • 經直腸
  • 市場魅力分析:各給藥途徑

第8章 全球慢性特發性便秘治療市場分析與預測:各流通管道

  • 簡介&定義
  • 主要調查結果/發展
  • 全球市場規模預測 (以金額為準):各流通管道
    • 解決方案為基礎的方法
    • 固相為基礎的方法
  • 市場魅力分析:各流通管道

第9章 全球慢性特發性便秘治療市場分析與預測:各地區

  • 主要調查結果
  • 全球市場規模預測 (以金額為準):各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析:各地區

第10章 北美的慢性特發性便秘治療市場分析與預測

  • 簡介
    • 主要調查結果
  • 北美的市場規模預測 (以金額為準):各醫藥品分類
  • 北美的市場規模預測 (以金額為準):各給藥途徑
  • 北美的市場規模預測 (以金額為準):各流通管道
  • 北美的市場規模預測 (以金額為準):各國
    • 美國
    • 加拿大
  • 北美的市場魅力分析
    • 各醫藥品分類
    • 各給藥途徑
    • 各流通管道
    • 各國

第11章 歐洲的慢性特發性便秘治療市場分析與預測

第12章 亞太地區的慢性特發性便秘治療市場分析與預測

第13章 南美的慢性特發性便秘治療市場分析與預測

第14章 中東及非洲的慢性特發性便秘治療市場分析與預測

第15章 競爭情形

  • 市場參與企業-競爭矩陣(企業層級·各規模)
  • 市場排行榜分析:各企業
  • 企業簡介
    • Bayer AG
    • Allergan
    • Bausch Health
    • Sanofi
    • Takeda Pharmaceutical Company
    • SEBELA PHARMACEUTICALS
    • Ironwood Pharmaceuticals, Inc.
    • Albireo Pharma, Inc.
    • Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
    • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
目錄
Product Code: TMRGL20537

Title:
Chronic Idiopathic Constipation Treatment Market (Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, and Others; Route of Administration: Oral and Rectal; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030(CIC) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030.

Chronic Idiopathic Constipation Treatment Market - Scope of the Report

TMR's report on the global chronic idiopathic constipation treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global chronic idiopathic constipation treatment market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global chronic idiopathic constipation treatment market during the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global chronic idiopathic constipation treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global chronic idiopathic constipation treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global chronic idiopathic constipation treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global chronic idiopathic constipation treatment market.

The report delves into the competition landscape of the global chronic idiopathic constipation treatment market. Key players operating in the global chronic idiopathic constipation treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global chronic idiopathic constipation treatment market that have been profiled in this report.

Key Questions Answered in Chronic Idiopathic Constipation Treatment Market Report

What is the scope of growth for product companies in the global chronic idiopathic constipation treatment market?

What will be the Y-o-Y growth of the global chronic idiopathic constipation treatment market between 2020 and 2030?

What is the influence of changing trends in technologies on the global chronic idiopathic constipation treatment market?

Will North America continue to be the most profitable market for chronic idiopathic constipation treatment?

Which factors are anticipated to hamper the global chronic idiopathic constipation treatment market during the forecast period?

Which are the leading companies in the global chronic idiopathic constipation treatment market?

Research Methodology

A unique methodology has been utilized by TMR to conduct comprehensive research on the growth of the global chronic idiopathic constipation treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global chronic idiopathic constipation treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the chronic idiopathic constipation treatment market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the chronic idiopathic constipation treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global chronic idiopathic constipation treatment market with accuracy. The study also uses the top-down approach to assess the revenues of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global chronic idiopathic constipation treatment more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chronic Idiopathic Constipation Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Drug Class Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Chronic Idiopathic Constipation Treatment Market Analysis and Forecast, 2018-2030

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
  • 5.3. Diseases Prevalence by Global/Sub-region
  • 5.4. Key Developments

6. Global Chronic Idiopathic Constipation Treatment Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
    • 6.3.1. Serotonin-4 (5-Ht4) Receptor Agonist
      • 6.3.1.1. Prucalopride
      • 6.3.1.2. Others
    • 6.3.2. Guanylate Cyclase-C Agonist
      • 6.3.2.1. Plecanatide
      • 6.3.2.2. Linaclotide
    • 6.3.3. Laxatives
      • 6.3.3.1. Sodium Picosulphate
      • 6.3.3.2. Polycarbophil
      • 6.3.3.3. Others
    • 6.3.4. Stimulants
      • 6.3.4.1. Bisacodyl
      • 6.3.4.2. Senokot
      • 6.3.4.3. Others
    • 6.3.5. Others
  • 6.4. Global Chronic Idiopathic Constipation Treatment Market Attractiveness, by Drug Class

7. Global Chronic Idiopathic Constipation Treatment Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
    • 7.3.1. Oral
    • 7.3.2. Rectal
  • 7.4. Global Chronic Idiopathic Constipation Treatment Market Attractiveness, by Route of Administration

8. Global Chronic Idiopathic Constipation Treatment Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Global Chronic Idiopathic Constipation Treatment Market Attractiveness, by Distribution Channel

9. Global Chronic Idiopathic Constipation Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Chronic Idiopathic Constipation Treatment Market Attractiveness, by Region

10. North America Chronic Idiopathic Constipation Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
    • 10.2.1. Serotonin-4 (5-Ht4) Receptor Agonist
      • 10.2.1.1. Prucalopride
      • 10.2.1.2. Others
    • 10.2.2. Guanylate Cyclase-C Agonist
      • 10.2.2.1. Plecanatide
      • 10.2.2.2. Linaclotide
    • 10.2.3. Laxatives
      • 10.2.3.1. Sodium Picosulphate
      • 10.2.3.2. Polycarbophil
      • 10.2.3.3. Others
    • 10.2.4. Stimulants
      • 10.2.4.1. Bisacodyl
      • 10.2.4.2. Senokot
      • 10.2.4.3. Others
    • 10.2.5. Others
  • 10.3. North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
    • 10.3.1. Oral
    • 10.3.2. Rectal
  • 10.4. North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country, 2018-2030
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis
    • 10.6.1. By Drug Class
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Chronic Idiopathic Constipation Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
    • 11.2.1. Serotonin-4 (5-Ht4) Receptor Agonist
      • 11.2.1.1. Prucalopride
      • 11.2.1.2. Others
    • 11.2.2. Guanylate Cyclase-C Agonist
      • 11.2.2.1. Plecanatide
      • 11.2.2.2. Linaclotide
    • 11.2.3. Laxatives
      • 11.2.3.1. Sodium Picosulphate
      • 11.2.3.2. Polycarbophil
      • 11.2.3.3. Others
    • 11.2.4. Stimulants
      • 11.2.4.1. Bisacodyl
      • 11.2.4.2. Senokot
      • 11.2.4.3. Others
    • 11.2.5. Others
  • 11.3. Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
    • 11.3.1. Oral
    • 11.3.2. Rectal
  • 11.4. Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis
    • 11.6.1. By Drug Class
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Chronic Idiopathic Constipation Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
    • 12.2.1. Serotonin-4 (5-Ht4) Receptor Agonist
      • 12.2.1.1. Prucalopride
      • 12.2.1.2. Others
    • 12.2.2. Guanylate Cyclase-C Agonist
      • 12.2.2.1. Plecanatide
      • 12.2.2.2. Linaclotide
    • 12.2.3. Laxatives
      • 12.2.3.1. Sodium Picosulphate
      • 12.2.3.2. Polycarbophil
      • 12.2.3.3. Others
    • 12.2.4. Stimulants
      • 12.2.4.1. Bisacodyl
      • 12.2.4.2. Senokot
      • 12.2.4.3. Others
    • 12.2.5. Others
  • 12.3. Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
    • 12.3.1. Oral
    • 12.3.2. Rectal
  • 12.4. Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis
    • 12.6.1. By Drug Class
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Chronic Idiopathic Constipation Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
    • 13.2.1. Serotonin-4 (5-Ht4) Receptor Agonist
      • 13.2.1.1. Prucalopride
      • 13.2.1.2. Others
    • 13.2.2. Guanylate Cyclase-C Agonist
      • 13.2.2.1. Plecanatide
      • 13.2.2.2. Linaclotide
    • 13.2.3. Laxatives
      • 13.2.3.1. Sodium Picosulphate
      • 13.2.3.2. Polycarbophil
      • 13.2.3.3. Others
    • 13.2.4. Stimulants
      • 13.2.4.1. Bisacodyl
      • 13.2.4.2. Senokot
      • 13.2.4.3. Others
    • 13.2.5. Others
  • 13.3. Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
    • 13.3.1. Oral
    • 13.3.2. Rectal
  • 13.4. Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis
    • 13.6.1. By Drug Class
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
    • 14.2.1. Serotonin-4 (5-Ht4) Receptor Agonist
      • 14.2.1.1. Prucalopride
      • 14.2.1.2. Others
    • 14.2.2. Guanylate Cyclase-C Agonist
      • 14.2.2.1. Plecanatide
      • 14.2.2.2. Linaclotide
    • 14.2.3. Laxatives
      • 14.2.3.1. Sodium Picosulphate
      • 14.2.3.2. Polycarbophil
      • 14.2.3.3. Others
    • 14.2.4. Stimulants
      • 14.2.4.1. Bisacodyl
      • 14.2.4.2. Senokot
      • 14.2.4.3. Others
    • 14.2.5. Others
  • 14.3. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
    • 14.3.1. Oral
    • 14.3.2. Rectal
  • 14.4. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis
    • 14.6.1. By Drug Class
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis/Ranking By Company (2019)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Company Financials
      • 15.3.1.3. Growth Strategies
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Allergan
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Company Financials
      • 15.3.2.3. Growth Strategies
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. Bausch Health
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Company Financials
      • 15.3.3.3. Growth Strategies
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Sanofi
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Company Financials
      • 15.3.4.3. Growth Strategies
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. Takeda Pharmaceutical Company
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Company Financials
      • 15.3.5.3. Growth Strategies
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. SEBELA PHARMACEUTICALS
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Growth Strategies
      • 15.3.6.3. SWOT Analysis
    • 15.3.7. Ironwood Pharmaceuticals, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Company Financials
      • 15.3.7.3. Growth Strategies
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Albireo Pharma, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Company Financials
      • 15.3.8.3. Growth Strategies
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Company Financials
      • 15.3.9.3. Growth Strategies
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Company Financials
      • 15.3.10.3. Growth Strategies
      • 15.3.10.4. SWOT Analysis

List of Tables

  • Table 01: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 02: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Table 03: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Guanylate Cyclase-C Agonist, 2018-2030
  • Table 04: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2018-2030
  • Table 05: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Stimulants, 2018-2030
  • Table 06: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 07: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 08: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 09: North America Chronic Idiopathic Constipation Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 10: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 11: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Table 12: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Guanylate Cyclase-C Agonist, 2018-2030
  • Table 13: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2018-2030
  • Table 14: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Stimulants, 2018-2030
  • Table 15: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 16: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 17: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 18: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 19: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Table 20: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Guanylate Cyclase-C Agonist, 2018-2030
  • Table 21: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2018-2030
  • Table 22: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Stimulants, 2018-2030
  • Table 23: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 24: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 25: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 26: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 27: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Table 28: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Guanylate Cyclase-C Agonist, 2018-2030
  • Table 29: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2018-2030
  • Table 30: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Stimulants, 2018-2030
  • Table 31: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 32: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 33: Latin America Chronic Idiopathic Constipation Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 34: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 35: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Table 36: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Guanylate Cyclase-C Agonist, 2018-2030
  • Table 37: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2018-2030
  • Table 38: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Stimulants, 2018-2030
  • Table 39: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 40: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 41: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 42: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 43: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Table 44: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Guanylate Cyclase-C Agonist, 2018-2030
  • Table 45: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Laxatives, 2018-2030
  • Table 46: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Stimulants, 2018-2030
  • Table 47: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 48: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 01: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 02: Global Chronic Idiopathic Constipation Treatment Market Value Share, by Drug Class, 2019
  • Figure 03: Global Chronic Idiopathic Constipation Treatment Market Value Share, by Route of Administration, 2019
  • Figure 04: Global Chronic Idiopathic Constipation Treatment Market Value Share, by Distribution Channel, 2019
  • Figure 05: Global Chronic Idiopathic Constipation Treatment Market Value Share, by Region, 2019
  • Figure 06: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 07: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 08: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Serotonin-4 (5-Ht4) Receptor Agonist, 2018-2030
  • Figure 09: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Guanylate Cyclase-C Agonist, 2018-2030
  • Figure 10: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Laxatives, 2018-2030
  • Figure 11: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Stimulants, 2018-2030
  • Figure 12: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Others, 2018-2030
  • Figure 13: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Serotonin-4 (5-Ht4) Receptor Agonist, 2019 and 2030
  • Figure 14: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Serotonin-4 (5-Ht4) Receptor Agonist, 2020-2030
  • Figure 15: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Guanylate Cyclase-C Agonist, 2019 and 2030
  • Figure 16: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Guanylate Cyclase-C Agonist, 2020-2030
  • Figure 17: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Laxatives, 2019 and 2030
  • Figure 18: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Laxatives, 2020-2030
  • Figure 19: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Stimulants, 2019 and 2030
  • Figure 20: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Stimulants, 2020-2030
  • Figure 21: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 22: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 23: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Oral, 2018-2030
  • Figure 24: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Rectal, 2018-2030
  • Figure 25: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 26: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 27: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Hospital Pharmacies, 2018-2030
  • Figure 28: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Retail Pharmacies, 2018-2030
  • Figure 29: Global Chronic Idiopathic Constipation Treatment Market Value (US$ Mn), by Online Pharmacies, 2018-2030
  • Figure 30: Global Chronic Idiopathic Constipation Treatment Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 31: Global Chronic Idiopathic Constipation Treatment Market Attractiveness Analysis, by Region
  • Figure 32: North America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 33: North America Chronic Idiopathic Constipation Market Value Share (%), by Country, 2019 and 2030
  • Figure 34: North America Chronic Idiopathic Constipation Market Attractiveness, by Country, 2020-2030
  • Figure 35: North America Chronic Idiopathic Constipation Treatment Market Value Share (%), by Drug Class, 2019 and 2030
  • Figure 36: North America Chronic Idiopathic Constipation Treatment Market Attractiveness, by Drug Class, 2020-2030
  • Figure 37: North America Chronic Idiopathic Constipation Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 38: North America Chronic Idiopathic Constipation Treatment Market Attractiveness, by Route of Administration, 2020-2030
  • Figure 39: North America Chronic Idiopathic Constipation Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 40: North America Chronic Idiopathic Constipation Treatment Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 41: Europe Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 42: Europe Chronic Idiopathic Constipation Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 43: Europe Chronic Idiopathic Constipation Treatment Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 44: Europe Chronic Idiopathic Constipation Treatment Market Value Share (%), by Drug Class, 2019 and 2030
  • Figure 45: Europe Chronic Idiopathic Constipation Treatment Market Attractiveness, by Drug Class, 2020-2030
  • Figure 46: Europe Chronic Idiopathic Constipation Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 47: Europe Chronic Idiopathic Constipation Treatment Market Attractiveness, by Route of Administration, 2020-2030
  • Figure 48: Europe Chronic Idiopathic Constipation Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 49: Europe Chronic Idiopathic Constipation Treatment Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 50: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 51: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 52: Asia Pacific Chronic Idiopathic Constipation Treatment Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 53: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value Share (%), by Drug Class, 2019 and 2030
  • Figure 54: Asia Pacific Chronic Idiopathic Constipation Treatment Market Attractiveness, by Drug Class, 2020-2030
  • Figure 55: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 56: Asia Pacific Chronic Idiopathic Constipation Treatment Market Attractiveness, by Route of Administration, 2020-2030
  • Figure 57: Asia Pacific Chronic Idiopathic Constipation Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 58: Asia Pacific Chronic Idiopathic Constipation Treatment Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 59: Latin America Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 60: Latin America Chronic Idiopathic Constipation Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 61: Latin America Chronic Idiopathic Constipation Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 62: Latin America Chronic Idiopathic Constipation Treatment Market Value Share (%), by Drug Class, 2019 and 2030
  • Figure 63: Latin America Chronic Idiopathic Constipation Treatment Market Attractiveness, by Drug Class, 2020-2030
  • Figure 64: Latin America Chronic Idiopathic Constipation Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 65: Latin America Chronic Idiopathic Constipation Treatment Market Attractiveness, by Route of Administration, 2020-2030
  • Figure 66: Latin America Chronic Idiopathic Constipation Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 67: Latin America Chronic Idiopathic Constipation Treatment Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 68: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 69: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 70: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 71: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value Share (%), by Drug Class, 2019 and 2030
  • Figure 72: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Attractiveness, by Drug Class, 2020-2030
  • Figure 73: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 74: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Attractiveness, by Route of Administration, 2020-2030
  • Figure 75: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 76: Middle East & Africa Chronic Idiopathic Constipation Treatment Market Attractiveness, by Distribution Channel, 2020-2030